Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins MWG Operon Opens Sanger Sequencing Facility in California


Expanding its sequencing operations to the West Coast, Eurofins MWG Operon has opened a Sanger sequencing facility in Petaluma, Calif.

The new facility, which shares a building with an existing sister company, Eurofins Scientific Supplement Analysis Center, offers DNA sequencing services to customers in and around Northern California on Life Technologies' Applied Biosystems 3730xl capillary instruments.

Overnight sequencing will be available to customers in the San Francisco Bay Area, and next-day sequencing services to other customers in the Western US. Customers in the San Francisco area can also receive daily sample pick-up.

The new laboratory complements Eurofins MWG Operon's existing US sequencing facility in Huntsville, Ala., which will continue to provide Sanger sequencing, next-generation sequencing, and other genomic services to customers in North and South America.

Martin Kunz, the company's CEO, said in a statement that the new facility resulted from strong growth in the firm's DNA sequencing business and will "bring us closer to a key area of the country so that we can provide faster turnaround times."

Eurofins MWG Operon, a member of the Eurofins Group, provides a variety of genomic services. The company has European headquarters in Ebersberg, Germany, and US headquarters in Huntsville.

Besides Sanger sequencing, the company offers next-gen sequencing services on the 454 GS FLX and GS Junior, Illumina HiSeq 2000, and PacBio RS (IS 5/31/2011).

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.